Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00058396
Status:
COMPLETED
Last Update Posted:
2013-05-30
First Post:
2003-04-07
Brief Title:
Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| refractory chronic lymphocytic leukemia | View |
| stage I chronic lymphocytic leukemia | View |
| stage II chronic lymphocytic leukemia | View |
| stage III chronic lymphocytic leukemia | View |
| stage IV chronic lymphocytic leukemia | View |
| noncontiguous stage II small lymphocytic lymphoma | View |
| recurrent small lymphocytic lymphoma | View |
| stage I small lymphocytic lymphoma | View |
| stage III small lymphocytic lymphoma | View |
| stage IV small lymphocytic lymphoma | View |
| contiguous stage II small lymphocytic lymphoma | View |